Free Trial

Zacks Research Analysts Reduce Earnings Estimates for DLB

Dolby Laboratories logo with Consumer Discretionary background

Dolby Laboratories, Inc. (NYSE:DLB - Free Report) - Stock analysts at Zacks Research dropped their Q4 2024 EPS estimates for shares of Dolby Laboratories in a note issued to investors on Tuesday, October 29th. Zacks Research analyst V. Doshi now expects that the electronics maker will post earnings of $0.43 per share for the quarter, down from their previous estimate of $0.44. The consensus estimate for Dolby Laboratories' current full-year earnings is $2.72 per share. Zacks Research also issued estimates for Dolby Laboratories' Q2 2025 earnings at $0.85 EPS, Q4 2025 earnings at $0.63 EPS and FY2025 earnings at $2.68 EPS.

Dolby Laboratories (NYSE:DLB - Get Free Report) last issued its quarterly earnings data on Wednesday, August 7th. The electronics maker reported $0.47 EPS for the quarter, topping analysts' consensus estimates of $0.33 by $0.14. Dolby Laboratories had a net margin of 16.87% and a return on equity of 10.66%. The firm had revenue of $288.82 million for the quarter, compared to analyst estimates of $286.26 million.

Separately, Barrington Research reissued an "outperform" rating and issued a $100.00 target price on shares of Dolby Laboratories in a research report on Friday, September 20th.

View Our Latest Research Report on DLB

Dolby Laboratories Trading Down 0.6 %

DLB stock traded down $0.44 during trading on Thursday, reaching $72.96. The stock had a trading volume of 190,181 shares, compared to its average volume of 401,989. Dolby Laboratories has a 1-year low of $66.35 and a 1-year high of $90.06. The company has a market capitalization of $6.99 billion, a P/E ratio of 37.19 and a beta of 0.97. The firm has a fifty day moving average price of $72.82 and a 200 day moving average price of $76.55.

Institutional Investors Weigh In On Dolby Laboratories

A number of institutional investors have recently modified their holdings of the business. First Affirmative Financial Network grew its position in shares of Dolby Laboratories by 4.9% during the 2nd quarter. First Affirmative Financial Network now owns 2,766 shares of the electronics maker's stock valued at $219,000 after buying an additional 129 shares during the last quarter. LRI Investments LLC grew its position in Dolby Laboratories by 6.0% in the 2nd quarter. LRI Investments LLC now owns 2,293 shares of the electronics maker's stock worth $182,000 after purchasing an additional 130 shares during the last quarter. Signaturefd LLC grew its position in Dolby Laboratories by 5.1% in the 2nd quarter. Signaturefd LLC now owns 3,167 shares of the electronics maker's stock worth $251,000 after purchasing an additional 153 shares during the last quarter. Mitchell & Pahl Private Wealth LLC grew its position in Dolby Laboratories by 1.3% in the 2nd quarter. Mitchell & Pahl Private Wealth LLC now owns 13,817 shares of the electronics maker's stock worth $1,095,000 after purchasing an additional 174 shares during the last quarter. Finally, GAMMA Investing LLC grew its position in Dolby Laboratories by 64.6% in the 2nd quarter. GAMMA Investing LLC now owns 489 shares of the electronics maker's stock worth $39,000 after purchasing an additional 192 shares during the last quarter. Institutional investors own 58.56% of the company's stock.

Insider Activity at Dolby Laboratories

In related news, CEO Kevin J. Yeaman sold 28,512 shares of the business's stock in a transaction dated Tuesday, October 15th. The shares were sold at an average price of $74.12, for a total transaction of $2,113,309.44. Following the completion of the sale, the chief executive officer now owns 83,721 shares of the company's stock, valued at $6,205,400.52. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 39.54% of the company's stock.

Dolby Laboratories declared that its board has approved a stock repurchase program on Wednesday, August 7th that permits the company to repurchase $350.00 million in shares. This repurchase authorization permits the electronics maker to reacquire up to 5% of its stock through open market purchases. Stock repurchase programs are often an indication that the company's management believes its shares are undervalued.

Dolby Laboratories Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, August 27th. Stockholders of record on Monday, August 19th were given a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 1.64%. The ex-dividend date was Monday, August 19th. Dolby Laboratories's payout ratio is currently 61.22%.

About Dolby Laboratories

(Get Free Report)

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.

Read More

Earnings History and Estimates for Dolby Laboratories (NYSE:DLB)

→ Trump won. Buy this coin now. (From Weiss Ratings) (Ad)

Should you invest $1,000 in Dolby Laboratories right now?

Before you consider Dolby Laboratories, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dolby Laboratories wasn't on the list.

While Dolby Laboratories currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines